BMX and synovial sarcoma: In order to assess the specificity of the BMX-IN-1 inhibitor, we applied similar experimental conditions to primary spheroid cultures derived from 2 other pediatric tumors, Ewing and Synovial sarcoma, which displayed very low BMX expression levels (Supplemental Figure 2F).